IOL Radio Podcast: Dr Nora Tabori and Dr Riad Salem discuss LEGACY, a robust multicenter study confirming Boston Scientific’s TheraSphere™ as a neoadjuvant or standalone therapy in treating HCC.
Dr DeNittis discusses NuView Life Science’s VPAC1, a peptide platform that detects the overexpression of specific receptors that appear only on the surface of malignant cells for early diagnosis and therapy of cancer.
Backtable Podcast Episode #81: Interventional Radiologist Dr Eric Monroe from Seattle Children's walks us through Intra-Arterial Chemotherapy (IAC) for treatment of Retinoblastoma. In certain patients with retinoblastoma, IAC is a safe and effective…